Adempas- 1MG tab-90CT. Bottle
Ended Awarded Last action
- Contract number
- 15B50526F00000095
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Federal Medical Center Carswell
Correctional Facilities, Department of Justice
- Obligated
- $12,153
Award facts
- Contract value 100% obligated
- $12,153.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
About this award
Bayer Healthcare Pharmaceuticals Inc. received a delivery order valued at $12,153.05 from the Federal Medical Center Carswell for 90-count bottles of Adempas 1mg tablets, with an ultimate completion date of February 28, 2026. The award was made on February 1, 2026, under a firm fixed-price contract type with no small business set-aside designation. The place of performance is listed as Whippany, Hanover, New Jersey, where Bayer maintains its principal operations facility. This delivery order falls under Bayer's larger $840 million multiple-award Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the Department of Veterans Affairs, which enables federal agencies to procure pharmaceutical products at pre-negotiated pricing.
Adempas (riociguat) is a specialized medication used to treat pulmonary arterial hypertension, and Bayer Healthcare Pharmaceuticals Inc. serves as a primary supplier of this single-source drug to federal healthcare systems. The Federal Medical Center Carswell, a civilian healthcare facility within the federal system, issued this delivery order to support its patient care requirements. Bayer's role as a reliable supplier of critical, often limited-manufacturer medications is reinforced by its established position within federal healthcare networks, including Veterans Integrated Service Networks and Defense Health Agency facilities, which regularly issue task orders for specialized pharmaceutical products including radiopharmaceuticals and cardiovascular treatments.
Quick answers
Who was awarded contract 15B50526F00000095?
15B50526F00000095 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Federal Medical Center Carswell (Correctional Facilities) on February 1, 2026.
How much is contract 15B50526F00000095 worth?
The government has obligated $12,153 on 15B50526F00000095.
Is contract 15B50526F00000095 an order under another contract?
Yes. 15B50526F00000095 is a delivery order under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50526F00000095 competed?
The extent of competition for 15B50526F00000095 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award